Drug reference
Postpartum haemorrhage due to uterine atony in patients unresponsive to ergometrine and oxytocin ▶BY DEEP INTRAMUSCULAR INJECTION ▶Adult: 250 micrograms, repeated if necessary, to be given at intervals of not less than 15 minutes. Total dose should not exceed 2 mg (8 doses)
PDF page 892
Cardiac disease. pulmonary disease . untreated pelvic infection
PDF page 892
Excessive dosage may cause uterine rupture. history of anaemia. history of asthma. history of diabetes. history of epilepsy. history of glaucoma. history of hypertension. history of hypotension. history of jaundice. history of raised intra-ocular pressure. uterine scars
PDF page 892
▶Common or very common Chills. cough. diarrhoea. headache. nausea. uterine disorders. vasodilation. vomiting ▶Uncommon Abdominal pain upper. asthma. back pain. breast tenderness. chest discomfort. dizziness. drowsiness. dry mouth. dyspnoea. eye pain. haemorrhage . hiccups. hyperhidrosis. hypertension. increased risk of infection. movement disorders. muscle complaints. paraesthesia. pelvic pain. respiratory disorders. septic shock. sleep disorder. syncope. tachycardia. taste altered . tinnitus. uterine injuries. vertigo. vision blurred ▶Frequency not known Anxiety. asthenia. blepharospasm. choking sensation. palpitations. rash. thirst. throat complaints. thyrotoxic crisis
PDF page 892
Manufacturer advises avoid in active hepatic disease.
PDF page 892
Manufacturer advises avoid.
PDF page 892
There can be variation in the licensing of different medicines containing the same drug. Solution for injection ▶Hemabate (Pfizer Ltd) Carboprost (as Carboprost trometamol) 250 microgram per 1 ml Hemabate 250micrograms/1ml solution for injection ampoules | 10 ampoule P £182.01 (Hospital only) 5.3 Premature labour Other drugs used for Premature labour Indometacin, p. 1206. Nifedipine, p. 174. Salbutamol, p. 267. Terbutaline sulfate, p. 269 OXYTOCIN RECEPTOR ANTAGONISTS
PDF pages 892, 893
250 micrograms, repeated if necessary, to be
First-line fragment. Read the complete Indications and Dose section above.
PDF page 892
